Pulmonx announces inducement equity grants under Nasdaq Rule 5635(c)(4)
Pulmonx (LUNG) said it granted equity awards on September 1, 2026 under its 2025 inducement grants program tied to Nasdaq Listing Rule 5635(c)(4).
REDWOOD CITY, Calif., Sept.
01, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation NASDAQ:LUNG (the “Company” or “Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that on September 1, 2026 (the “Grant Date”), Pulmonx granted equity awards under its 2025 Induce…